Please login to the form below
Eklira
This page shows the latest Eklira news and features for those working in and with pharma, biotech and healthcare.
AZ adds to respiratory portfolio with Actavis drugs
It follows a similar deal agreed in July last year for AZ to buy the global respiratory portfolio of Almirall for $2bn, including the approved Eklira (aclidinium) for COPD and several
Latest news
-
AstraZeneca signs $2bn deal to buy Almirall respiratory portfolio
Almirall's franchise includes Eklira (aclidinium), LAS40464 (a combination of aclidinium with formoterol, which has been filed in Europe), LAS100977 (abediterol), a once-daily phase II long-acting beta2-agonist (LABA),
-
Almirall expands in US via $400m deal to buy Aqua
under 22m on the back of high roll-out costs for new products such as Sativex (nabiximols) for spasticity in multiple sclerosis (MS) and chronic obstructive pulmonary disorder (COPD) treatment Eklira
-
IQWiG knocks back Almirall's Eklira
IQWiG knocks back Almirall's Eklira. Decides added benefit of COPD drug is not proven. ... A long-acting bronchodilator, Eklira is licensed to treat adults with chronic-obstructive pulmonary disease (COPD) and works by widening their narrowed airways.
-
Forest Labs launches COPD drug Tudorza in US
sold as Eklira and Bretaris Genuair.
-
Almirall's IBS drug Constella backed by CHMP
COPD) treatment Eklira/Tudorza (aclidinium bromide).
More from news
Approximately 2 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
Deal Watch table for November 2014
Eklira and Duaklir. Business unit acquisition. 3, 075. Pfizer / Merck KGaA.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Director, Market Access / HEOR - North-West
-
Negotiable
-
Associate Director
-
£75, 000-90, 000
- Principal Health Economist - North-West
-
Negotiable
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
-
Senior Medical Writer
-
Competitive Salary
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Medical Writers
-
Competitive Salary and Benefits
- Account Manager- Healthcare Advertising
-
Negotiable
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
Subscribe to our email news alerts
- Heart Lung Machine Market to See 6.9% CAGR Growth to 2025: Growth Factor & Trends
- Ultrasonic Dental Unit Market Trends Shows a Steady 0.3% CAGR Growth to 2023: Market Study Report
- Prefilled Syringe Market Set to Register 9.0% CAGR to 2023: Market Study Report
- Carbide Tipped Needle Holders Market to Grow at a 14.5 % CAGR to 2023
- Keyhole Limpet Hemocyanin (KLH) Market Set to Register 1.2% CAGR to 2023: Market Study Report
- Medical Refrigerator Market Set to Register 2.4% CAGR to 2023
PMHub
M3 (EU)
M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
